Microbot Medical receives 510(k) clearance for LIBERTY robotic system

Microbot Medical (MBOT) announced that the U.S. Food and Drug Administration has granted 510(k) clearance for the LIBERTY System, the first FDA cleared single-use, remotely operated robotic system for peripheral endovascular procedures. The FDA clearance positions the Company to commercialize LIBERTY in the U.S., with the goal of transforming the field to enable accessibility to advanced robotics without the traditional constraints of capital equipment and a dedicated infrastructure.